Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer

被引:0
|
作者
Yuichi Ozawa
Daisuke Akahori
Keigo Koda
Takefumi Abe
Hirotsugu Hasegawa
Takashi Matsui
Masayuki Tanahashi
Hiroshi Niwa
Kazunari Yamada
Koshi Yokomura
Takafumi Suda
机构
[1] Seirei Mikatahara General Hospital,Department of Respiratory Medicine, Respiratory Disease Center
[2] Seirei Mikatahara General Hospital,Division of Thoracic Surgery, Respiratory Disease Center
[3] Seirei Mikatahara General Hospital,Department of Radiation Oncology
[4] Hamamatsu University School of Medicine,Second Division, Department of Internal Medicine
来源
关键词
Lung cancer; Interstitial lung disease; Docetaxel; S-1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1031 / 1038
页数:7
相关论文
共 50 条
  • [41] Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease
    Toshihito Otani
    Kakuhiro Yamaguchi
    Satoshi Nakao
    Shinjiro Sakamoto
    Yasushi Horimasu
    Takeshi Masuda
    Shintaro Miyamoto
    Taku Nakashima
    Hiroshi Iwamoto
    Kazunori Fujitaka
    Hironobu Hamada
    Noboru Hattori
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 857 - 865
  • [42] Characteristics of and Risk Factors for Interstitial Lung Disease Induced by Chemotherapy for Lung Cancer
    Sakurada, Takumi
    Kakiuchi, Soji
    Tajima, Soichiro
    Horinouchi, Yuya
    Okada, Naoto
    Nishisako, Hirotaka
    Nakamura, Toshimi
    Teraoka, Kazuhiko
    Kawazoe, Kazuyoshi
    Yanagawa, Hiroaki
    Nishioka, Yasuhiko
    Minakuchi, Kazuo
    Ishizawa, Keisuke
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (04) : 398 - 404
  • [43] PRE- EXISTING INTERSTITIAL LUNG ABNORMALITIES ARE RISK FACTORS FOR IMMUNE CHECKPOINT INHIBITORINDUCED INTERSTITIAL LUNG DISEASE IN NON-SMALL CELL LUNG CANCER
    Masuda, Takeshi
    Nakanishi, Yu
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Nakashima, Taku
    Miyamoto, Shintaro
    Iwamoto, Hiroshi
    Fujitaka, Kazunori
    Hamada, Hironobu
    Hattori, Noboru
    RESPIROLOGY, 2019, 24 : 248 - 249
  • [44] The Impact of Radiation Therapy on Lung Cancer Patients with Interstitial Lung Disease
    Genet, S.
    Yogiaveetil, E.
    Shaverdian, N.
    Wu, A.
    Simone, C. B., II
    Shin, J.
    Gelblum, D. Y.
    Iyengar, P.
    Rimner, A.
    Gomez, D. R.
    Shepherd, A. F.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S538 - S538
  • [45] Travel to high altitude with pre-existing lung disease
    Luks, A. M.
    Swenson, E. R.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (04) : 770 - 792
  • [46] LUNG TRAUMA - INFLUENCE OF PRE-EXISTING PULMONARY DISEASE
    LANE, WZ
    NEW ENGLAND JOURNAL OF MEDICINE, 1959, 260 (06): : 251 - 255
  • [47] Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-NSCLC cancers.
    Shimoji, Kiyofumi
    Masuda, Takeshi
    Nakanishi, Yu
    Yamaguchi, Kakuhiro
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Nakashima, Taku
    Miyamoto, Shintaro
    Iwamoto, Hiroshi
    Fujitaka, Kazunori
    Hamada, Hironobu
    Hattori, Noboru
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] THE CLASSIFICATION OF INTERSTITIAL PNEUMONIA BY THE OFFICIAL ATS/ERS/JRS/ALAT STATEMENT COULD PREDICT ACUTE EXACERBATION OF INTERSTITIAL LUNG DISEASE IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS WITH PRE-EXISTING INTERSTITIAL LUNG DISEASE
    Asai, Nobuhiro
    Katsuta, Eisuke
    Numanami, Hiroki
    Haniuda, Masayuki
    Yamaguchi, Etsuro
    Kubo, Akihito
    RESPIROLOGY, 2014, 19 : 163 - 163
  • [49] COVID-19 pneumonia can cause irreversible lung damage in dermatomyositis with pre-existing interstitial lung disease
    Hama, Satoshi
    Akiyama, Mitsuhiro
    Shimada, Tatsuya
    Higashida-Konishi, Misako
    Takei, Hiroshi
    Izumi, Keisuke
    Oshima, Hisaji
    Okano, Yutaka
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (09) : 1221 - 1223
  • [50] Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease
    Aksamit, TR
    CLINICS IN CHEST MEDICINE, 2002, 23 (03) : 643 - +